Repace -H

Quick links to important sections

Repace -H

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Repace -H

Property Description
Active ingredient Losartan Potassium, Hydrochlorothiazide (HCTZ)
Form Tablet (Fixed-dose combination)
Pharmacological class Combined Antihypertensive Preparation
General purpose Management of Hypertension (High Blood Pressure)
Origin Synthetic

Repace-H: Definition and Pharmacological Identity

Repace-H is a prescription-only, synthetic fixed-dose combination medication classified as a Combined Antihypertensive Preparation. It is delivered for oral administration in the dosage form of a tablet. This dual-agent medicine is specifically distinguished by the pairing of an Angiotensin II Receptor Antagonist (ARB) with a Thiazide Diuretic, a strategy that is clinically recognized for providing greater efficacy in achieving target blood pressure compared to monotherapy.


Composition and Dual-Action Active Ingredients

The precise composition of Repace-H centers on the two distinct active ingredients: Losartan Potassium and Hydrochlorothiazide (HCTZ). Both chemical substances are entirely synthetic in origin and are integrated within an excipient-based matrix. Losartan is a non-peptide molecule that selectively blocks specific receptors in the vascular system, while HCTZ is derived from the sulfonamide class and affects fluid balance in the kidneys. The use of a fixed-dose combination is a clinically accepted approach for improving efficacy in treating essential hypertension.

General Purpose of the Repace-H Combination

The overarching general purpose of Repace-H is the consistent, systemic management and control of chronically elevated blood pressure (hypertension). For instance, a typical scenario involves its use in adult patients whose pressure is not adequately controlled by a single anti-hypertensive agent. The synergistic effect of the combination works by simultaneously addressing two distinct physiological actions: Losartan facilitates the relaxation of blood vessels, and Hydrochlorothiazide assists the body in eliminating excess sodium and fluid. This integrated approach is designed to provide a robust and sustained anti-hypertensive effect for long-term pressure maintenance.

Regulatory References

  1. Losartan and Hydrochlorothiazide Drug Information

What side effects are possible with Repace -H?

Possible Side Effects and Safety Information

The safety profile for Repace-H (Losartan Potassium/Hydrochlorothiazide) is formally categorized by regulatory authorities, encompassing adverse reactions and strict safety constraints derived from the dual components of the medicine.

Frequency-Classified Adverse Reactions

The adverse effects are classified according to how often they have been officially documented in clinical studies, using regulatory standards (e.g., Common, Uncommon, Rare):

Classification Examples of Documented Effects (by SOC)
Common Dizziness, Headache, Upper respiratory infection, Back pain, Fatigue, Nausea, Diarrhea (Nervous, Respiratory, Musculoskeletal, Gastrointestinal disorders)
Uncommon Hypotension, Palpitations, Constipation, Photosensitivity, Erectile dysfunction, Gout (Cardiac, Gastrointestinal, Skin, Reproductive, Metabolic disorders)

Serious Adverse Reactions and Safety Constraints

Specific serious adverse reactions are explicitly documented in regulatory labeling:

  • Fetal Toxicity: Use during the second and third trimesters of pregnancy is Contraindicated due to the high risk of fetal injury and death.
  • Hypersensitivity: Rare, serious reactions such as Angioedema (swelling of the larynx, face, and tongue) are documented. If this occurs, the medication must be immediately and permanently discontinued.
  • Ophthalmological Risk: The Hydrochlorothiazide component carries a documented risk of developing Acute Angle-Closure Glaucoma and acute transient myopia.
  • Contraindications: The medicine is Contraindicated in patients with anuria, severe hepatic impairment, severe renal impairment (CrCl < 30 mL/min), and those with specific metabolic imbalances, including therapy-resistant hypokalemia or hypercalcemia.

Exposure-Related Safety Note

Long-term exposure to the Hydrochlorothiazide component is officially linked to an increased risk of Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma).

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

Official regulatory information describes overdose of Repace-H (Losartan Potassium/Hydrochlorothiazide) as an exaggeration of its expected effects, potentially leading to severe complications.

Documented Overdose Manifestations

System Documented Clinical Manifestations
Cardiovascular Hypotension (severely low blood pressure), Tachycardia (rapid heart rate), or Bradycardia (slow heart rate).
Metabolic/Renal Volume depletion, Hyponatremia (low sodium), Hypokalemia (low potassium), Dizziness, and Confusion.
Severe Outcomes Profound hypotension, Seizures, and Acute Respiratory Distress Syndrome (ARDS) are listed as possible severe outcomes [HPRA/FDA SmPC].

Immediate Emergency Action Required

If an overdose is suspected or confirmed, immediate medical attention is required, as documented by health authorities. Individuals must contact emergency services or a Poison Control Centre immediately, even if they are initially asymptomatic [MedlinePlus/FDA Guidance].

Urgent medical help must be sought if the affected individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened [MedlinePlus Guidance].

Management Notes (Official Statements)

  • Supportive Care: Management is symptomatic and supportive, particularly for low blood pressure, with treatments like intravenous fluid administration [FDA Prescribing Information].
  • Antidote: No specific antidote is known for either active component.
  • Monitoring: Continuous monitoring of vital signs, serum electrolytes, and ECG is required for patients under observation [NIH Guidance].
  • Dialysis: Hemodialysis is not effective for removing the Losartan component due to its high protein binding [EFDA SmPC].

Therapeutic Uses of Repace -H

Quick Facts

Condition Treated Primary Therapeutic Benefit
Hypertension (High Blood Pressure) Achieves and maintains blood pressure control
Stroke Risk Reduction Lowers the risk of stroke in patients with high blood pressure and an enlarged heart muscle
Cardiovascular Risk Reduction Reduces the potential for heart attack and other serious outcomes

Main Uses and Benefits

Repace-H is used to manage high blood pressure, a chronic medical condition known as hypertension. The medicine's combination of actions helps to control blood pressure more effectively than a single agent for many patients.

The primary therapeutic benefit of using Repace-H is achieving and maintaining blood pressure control. This control is vital because consistently high blood pressure can strain the cardiovascular system. By lowering blood pressure, the medication helps to reduce the risk of a stroke and lowers the overall risk of a heart attack and other serious cardiovascular events.

In specific patient populations, such as those with high blood pressure and left ventricular hypertrophy (enlarged heart muscle), Repace-H is indicated to lower the risk of stroke. It may also be used to assist in the control of fluid retention (edema) linked to heart conditions.

Use of this prescription product must be under the direction of a healthcare professional. Continuing treatment as prescribed is essential for sustained blood pressure management and risk mitigation.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Repace-H

Repace-H (Losartan Potassium and Hydrochlorothiazide) eligibility is strictly defined by regulatory documents based on physiological conditions, age, and pregnancy status. Use is generally established for adults with essential hypertension whose blood pressure is not adequately controlled by a single agent.

Absolute Contraindications

The medicine must not be used by certain populations due to high risk, as documented in official labeling:

  • Patients with hypersensitivity to any component of the medication, including sulfonamide-derived drugs.
  • Individuals with anuria (inability to produce urine) or severe renal impairment (creatinine clearance less than 30 mL/min).
  • Patients with severe hepatic impairment or biliary obstructive disorders.
  • Women in the second or third trimesters of pregnancy.
  • Patients with diabetes simultaneously receiving Aliskiren.

Restricted and Limited Use

Population Regulatory Status
Children and Adolescents (le 18 years) Not recommended (safety/efficacy not established).
Pregnancy (First Trimester) Not recommended; women must discontinue upon detection of pregnancy.
Lactating Mothers Not recommended; a choice to discontinue nursing or the drug is required.
Volume-Depleted Patients Restricted; volume or salt depletion must be corrected prior to use.

Older adults are generally permitted without the need for a routine dose adjustment.

What should I know about interactions with other medicines?

Repace-H interactions are officially documented across pharmacokinetic (PK) and pharmacodynamic (PD) domains, defining specific regulatory constraints. Coadministration is strictly contraindicated with Aliskiren in patients diagnosed with diabetes mellitus or those experiencing renal impairment with a GFR below 60 mL/ min/1.73 m^2. The combination is also contraindicated in cases of severe hepatic impairment.

Pharmacodynamically, co-administration with other agents that elevate serum potassium, such as potassium-sparing diuretics or potassium supplements, is not recommended due to the risk of hyperkalemia. Concurrent use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may diminish the documented antihypertensive and diuretic effects while increasing the risk of kidney function impairment. The combination is also noted to reduce the clearance of Lithium, which can lead to lithium toxicity.

In the PK category, substances modify drug exposure. Fluconazole officially decreases the systemic exposure of Losartan's active metabolite. Furthermore, the absorption of the Hydrochlorothiazide component is significantly reduced by Cholestyramine and Colestipol resins. To mitigate this effect, a strict timing rule is imposed: Hydrochlorothiazide must be administered at least 4 hours before or 4 to 6 hours after taking the resin. The use of alcohol is officially noted to potentiate the risk of orthostatic hypotension.

Mechanism of Action

Direct Molecular Target and Interaction

Repace-H exerts its effect through the selective inhibition of Cathepsin K (CTSK), a cysteine protease expressed predominantly by osteoclasts. This inhibition blocks the enzymatic degradation of Type I collagen and other non-collagenous proteins within the bone matrix. This action directly impedes the resorptive pit formation on the bone surface, which is the key process involved in osteoclast activity.

Cellular Cascade and Physiological Effect

The blockade of matrix degradation reduces the lysosomal release of demineralized bone components into the local microenvironment, resulting in a significantly reduced rate of overall bone matrix degradation. The primary mechanistic consequence is the maintenance of normal osteoclast function without inducing apoptosis (cell death). This action slows the rate of bone remodeling imbalance and consequently reduces the systemic release of specific bone turnover markers that signal excessive resorption.

Dosage and Administration Information

How Repace-H is Used: Official Administration Guidelines

Repace-H, a fixed-dose combination of Losartan and Hydrochlorothiazide, is intended for long-term management of chronic hypertension. The official instructions for use define a standardized once-daily oral administration protocol.

Administration and Scheduling

The medication is supplied as a tablet which must be swallowed whole and should not be crushed or split. It may be taken with or without food, providing flexibility in daily intake.

The starting dose for adults is typically the Losartan 50 mg / Hydrochlorothiazide 12.5 mg strength. The official regimen permits dose adjustment, or titration, to the maximum strength of 100 mg / 25 mg if blood pressure remains uncontrolled after an assessment period of approximately two to four weeks.

Procedural and Population Constraints

The combination product is generally not indicated for initial therapy of hypertension and is typically reserved for patients who have not responded adequately to monotherapy. Specific population-based constraints are outlined in the official labeling.

For patients with severely compromised kidney function, the medication is not recommended when creatinine clearance is ≤ 30 mL/min. Additionally, the safety and efficacy of this specific fixed-dose combination have not been established in pediatric patients.

In the event a dose is missed, official instructions specify that patients should not take a double dose; if it is near the time of the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Repace-H


Evidence for Management of High Blood Pressure (Essential Hypertension)

Research examining the use of Repace-H (the fixed-dose combination of Losartan and Hydrochlorothiazide) was primarily based on Randomized Controlled Trials (RCTs). These studies are applied in research exploring how blood pressure changes over defined time intervals. Research examined how this combined therapy was associated with changes in both the upper (systolic) and lower (diastolic) readings in adult patients with high blood pressure, including those whose pressure was not adequately controlled by taking a single medicine alone.

Research reports measurements taken during the study period when comparing the combination to its individual components or to other non-ARB blood pressure regimens. The findings describe patterns observed in the studies related to measurements of blood pressure goals over short treatment periods, typically lasting a few weeks to a few months. However, comparative evidence is lacking when it comes to long-term outcomes for the fixed-dose combination when measured directly against other modern two-drug regimens.


Evidence for Reducing Stroke Risk in High-Risk Patients

Research also examined long-term clinical outcomes that relate to cardiovascular health over several years in large-scale trials. These studies were applied in research contexts involving individuals with hypertension who were identified as being at higher risk due to Left Ventricular Hypertrophy (LVH), an enlarged heart muscle. The main research included examination of long-term outcomes, such as the incidence of fatal and non-fatal stroke.

Findings describe patterns related to stroke occurrence measurements when comparing the Losartan-based regimen (which frequently included the diuretic component) against an atenolol-based regimen. The findings reflect the specific conditions under which they were conducted. Regulatory summaries note that the findings regarding stroke risk reduction were not consistently seen in Black patients, a subgroup where limited information is available.


What is Still Uncertain About Repace-H

Comparative evidence is lacking for studies that directly tested the fixed-dose combination specifically against all other fixed-dose antihypertensive therapies. While studies monitored the Losartan component for many years, limited information exists for the long-term outcomes and durability of measurements related to the specific fixed-dose combination tablet. Data for other special populations, such as pediatric patients, remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Repace -H (FAQ)


Q: Is Repace -H a beta-blocker or a diuretic?

Repace-H is a combination medication containing two different types of blood pressure medicines. According to official product information, it is made up of an Angiotensin II Receptor Antagonist (Losartan) and a Thiazide Diuretic (Hydrochlorothiazide). It is not classified as a beta-blocker.


Q: Why would a doctor prescribe a combination pill like Repace -H instead of two separate pills?

Regulatory information indicates that combination products are typically used when high blood pressure is not adequately controlled by taking just one medicine alone. The combination of Losartan and Hydrochlorothiazide is recognized as a strategy to achieve greater blood pressure control when monotherapy is insufficient.


Q: What is the expected timeline for Repace -H to start lowering my blood pressure?

Official dosing guidelines indicate that healthcare providers may assess the need for a dosage change after approximately three weeks of therapy. This timeframe is consistent with the period used in clinical practice for assessing the medication's therapeutic effect.


Q: How long do the effects of one Repace -H tablet last?

The medication is approved for once-daily dosing. The diuretic component, Hydrochlorothiazide, is known to have an effect that can last for up to 24 hours.


Q: Is it normal to feel dizzy or lightheaded when starting Repace -H?

Dizziness is documented as a common adverse reaction in official product information. Low blood pressure (hypotension), which can cause a feeling of lightheadedness, is a possible occurrence, particularly when initiating therapy.


Q: Could Repace -H cause leg cramps or muscle aches?

Back pain and muscle spasm are documented as adverse reactions. Additionally, the diuretic component can sometimes lead to changes in electrolytes (like potassium), which in turn may be associated with muscle cramps.


Q: Does Repace -H have any known long-term side effects?

Yes, official safety labeling states that long-term exposure to the Hydrochlorothiazide component is linked to an increased risk of Non-Melanoma Skin Cancer, specifically Basal Cell Carcinoma and Squamous Cell Carcinoma.


Q: Can taking Repace -H affect my potassium levels?

Yes, regulatory documents indicate that Repace-H can cause changes to the levels of certain electrolytes. This includes the potential for both abnormally low potassium (hypokalemia) and high potassium (hyperkalemia).


Q: What kind of kidney function monitoring is usually done while on Repace -H?

Regulatory guidelines emphasize the importance of monitoring kidney function during treatment. This monitoring is especially important because the medication can affect renal function, and official labeling outlines restrictions for patients with severe kidney impairment.


Q: Are there any common foods or supplements that interact with Repace -H?

Official prescribing information advises that supplements or substitutes containing potassium should generally be reviewed with a healthcare provider due to the risk of high potassium levels (hyperkalemia). Specific common foods are not explicitly listed as contraindications in official labeling.


Q: Is Repace -H safe for people with diabetes?

Official prescribing information indicates a strict contraindication for patients with diabetes who are also taking Aliskiren. Additionally, the Hydrochlorothiazide component may have effects on blood sugar control.


Q: Does Repace -H interact with common cold or flu medications?

Official labeling specifically warns about the potential for interaction with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are found in many over-the-counter cold and flu preparations. The labeling does not generally detail other specific non-NSAID ingredients.


Q: Is Repace -H considered a long-term medication for high blood pressure?

Yes, official prescribing information explicitly states that Repace-H is intended for the long-term management of essential hypertension (high blood pressure).


Q: What is the likelihood of developing a persistent cough while on Repace -H?

Official adverse reaction lists document cough as a common side effect for this combination medication.


Q: Does Repace -H help protect the kidneys in addition to lowering blood pressure?

While the Losartan component is associated with overall cardiovascular benefits, such as reducing the risk of stroke in high-risk patients, kidney protection is not an explicitly listed indication for this specific combination product.


Q: Can Repace -H make me feel unusually tired or fatigued?

Yes, fatigue is officially documented as a common adverse reaction for this medication in clinical trials.


Q: Is fluid retention or swelling a possible side effect of Repace -H?

The Hydrochlorothiazide component acts as a diuretic to help the body eliminate excess fluid. However, a serious and rare type of swelling called Angioedema is listed as a possible side effect.


Q: Does Repace -H cause an increase in the need to urinate, and is that normal?

Yes, the Hydrochlorothiazide component is a diuretic, meaning it works by increasing the body's output of urine. This increased need to urinate is a normal and expected part of its mechanism to control blood pressure.


Q: How often should blood pressure be checked when starting Repace -H?

Dosage adjustments for this medication are typically considered after a period of approximately three weeks of therapy. The assessment for dosage change requires that blood pressure readings be taken during this timeframe to evaluate the therapeutic effect.


Q: Can I take Repace -H if I have a history of gout?

Gout has been reported as an uncommon adverse reaction with this medication. The Hydrochlorothiazide component may affect uric acid levels, which is relevant for individuals with a history of gout.


Q: Does Repace -H cause dry mouth or extreme thirst?

While constipation is an uncommon adverse reaction, symptoms like dry mouth and extreme thirst are signs of dehydration. These may be associated with the fluid-reducing effects of the diuretic component.


Q: Are there any reported interactions between Repace -H and herbal supplements?

Official drug labeling does not typically list specific herbal supplements. Regulatory materials advise that all products being used, including herbal supplements, should be reviewed by a healthcare provider.


Q: Can Repace -H be taken at the same time as other heart medications?

The medication is known to interact with specific drugs commonly used in cardiology (such as Aliskiren and certain potassium-raising agents). Co-administration with any other heart medication should be reviewed by a healthcare professional due to the potential for interactions.


Q: Is it better to take Repace -H in the morning or at night?

The medication is approved for once-daily administration. As one of its components is a diuretic, the timing of the dose may be discussed with a healthcare provider to manage the potential for increased nighttime urination.


Q: Does Repace -H affect blood sugar levels in non-diabetic people?

The Hydrochlorothiazide component is known to potentially affect blood sugar. It is associated with high blood sugar (hyperglycemia) and sugar in the urine (glycosuria).


Q: Why might Repace -H be prescribed when another blood pressure medicine wasn't working?

Official guidelines state that this combination product is generally not used as a first-line treatment for high blood pressure. It is typically reserved for patients whose pressure is not sufficiently controlled by an initial single blood pressure medicine.


Q: Does Repace -H affect a person's ability to drive or operate machinery?

Due to the potential for adverse effects like dizziness, caution may be necessary when performing tasks requiring mental alertness, such as driving or operating heavy machinery.


Q: Can lifestyle changes like diet and exercise reduce the need for Repace -H?

Official guidelines recommend that managing high blood pressure includes lifestyle approaches such as limiting sodium intake and engaging in exercise, which are components of the overall treatment plan.


Q: Does taking Repace -H affect vision or cause blurred vision?

Yes, the Hydrochlorothiazide component is associated with a risk of developing acute transient myopia (nearsightedness) and a serious condition called Acute Angle-Closure Glaucoma. Transient blurred vision is also a documented side effect.


Q: Is there a link between Repace -H and changes in appetite?

Loss of appetite (anorexia) is documented in the adverse reaction information, and is associated with the diuretic component of the medication.


Q: What is the main risk of an overdose of Repace -H?

The most likely symptoms of an overdose, according to regulatory information, are profoundly low blood pressure (hypotension), a very fast or very slow heart rate, and potential disturbances in the body’s electrolyte balance.

How should Repace -H be stored and disposed of?

How to Store and Dispose of Losartan Potassium and Hydrochlorothiazide

Repace-H tablets must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F), to maintain product stability.

Storage Requirements

  • Temperature: Store only within the specified controlled temperature range and keep from freezing.
  • Protection: The medicine must be protected from light and moisture.
  • Container: Keep the product in its original container and ensure the container is tightly closed.
  • Child Safety: It is mandatory to keep this medicine out of the reach of children.

Disposal

Do not dispose of this medication in household trash or by pouring it into wastewater. Unused or expired Losartan Potassium and Hydrochlorothiazide must be discarded according to local regulatory requirements and guidelines provided by your healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Repace -H found in:

A-Z Index: